mTOR inhibitors: temsirolimus and everolimus in the treatment of renal cell carcinoma;Inhibiteurs de mTOR : temsirolimus et évérolimus dans le traitement du cancer du rein.

Bulletin du cancer

Volumn 97, Issue , 2010, Pages 45-51

  Ravaud, A ^a   Bernhard, J C ^a   Gross Goupil, M ^a   Digue, L ^a   Ferriere, J M ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; RAPAMYCIN; SIGNAL PEPTIDE; TEMSIROLIMUS; VASCULOTROPIN RECEPTOR;

DRUG ANTAGONISM; DRUG EFFECT; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 77952536056     PISSN: None     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Review

References (39)